MAPK8 and colorectal carcinoma: We demonstrated, for the first time, that LCB potentiates apoptosis through the ROS-dependent JNK/p38 signaling pathway, suggesting that ROS are a potential therapeutic target for overcoming Ox resistance and that LCB may be a novel therapeutic agent for Ox-sensitive and -resistant CRC treatment.